On December 18, 2025, President Donald Trump signed Executive Order 14370, titled Increasing Medical Marijuana and Cannabidiol Research, directing Attorney General Pam Bondi to complete the rescheduling of marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) in the fastest way possible. And if you were watching the stock market that day, you would have thought cannabis companies had just won the lottery. Prices jumped. Financial headlines exploded. The mood was electric.